Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progression
Compose a Response to This Article
Other responses
No responses have been published for this article.
